Draft ‘Cures’ Bill Allows Advance Accelerated Approval Agreements

Latest iteration of House’s 21st Century Cures legislation drops brand exclusivity extensions that had been floated previously.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America